Nitric Oxide: From Research to Therapeutics

Prof. Arunabha Ray is Head, Dept. of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Hamdard University, New Delhi, India. He was formerly Director, Vallabhbhai Patel Chest Institute, University of Delhi, Director-Professor and Head, Department of Pharmacology at Vallabhbhai Patel Chest Institute, University of Delhi, and Dean, Faculty of Medical Sciences, University of Delhi. Prof. Ray graduated in Medicine from the University of Calcutta and subsequently obtained MD and PhD degrees in Pharmacology from the Faculty of Medicine, University of Delhi. He has more than 40 years of teaching and research experience in basic and clinical pharmacology and allied biomedical sciences. He received postdoctoral training in universities and institutes in Canada and USA and specialized in research skills in the area of neuropharmacology and immunopharmacology. During his academic career, he has mentored research of several postgraduate and doctoral students as well as postdoctoral fellows, who have later proceeded to make a mark for themselves as successful researchers/professionals in their chosen fields. Prof. Ray is internationally recognized as one of the leading exponents in the area of nitric oxide (NO) research. He showed through his innovative research that NO played a significant role as an endogenous regulatory molecule during stress and proposed NO mediated signaling pathways for stress induced anxiogenesis, immunomodulation, and gastric ulceration, as well as for stress adaptation. Prof. Ray continues to be a prolific researcher, and his research has been recognized at the highest level which has led to several awards, honors and fellowships. Prof. Ray has been invited to several global scientific platforms (most notably to several IUPHAR meetings), international academic institutions/universities to deliver lectures on his area of research expertise and has been the recipient of several honors/awards/fellowships throughout his career for his professional excellence. He has had collaborations with research laboratories in the academia and pharmaceutical industry both at the national and international levels and has been Visiting Professor to many reputed institutions/universities. He is chairperson and expert member at several national academic/scientific committees at leading institutions/universities/organizations and plays a key role in guiding ethical scientific research in basic and clinical pharmacology as well as allied areas. He has been actively associated with several professional bodies/societies in pharmacology as well as allied fields. Most notably, Prof. Ray is the President of the Society for Nitric Oxide and Allied Radicals (SNOAR) which was established by his initiative in 2011 for advancement of research in Nitric Oxide (NO) and allied radicals and organized several scientific meetings on the subject matter. He has more than 250 scientific publications (research papers, reviews, monographs, book chapters), has edited several reference books and authored a Textbook in Pharmacology.

Prof. Kavita Gulati is Director-Professor in Pharmacology at Vallabhbhai Patel Chest Institute, University of Delhi. She is an M.Sc in Pharmacology from the AIIMS, New Delhi, and subsequently Ph.D. from the Faculty of Medicine, University of Delhi. Dr. Gulati has 30 years of teaching and research experience in Clinical & Experimental Pharmacology and Toxicology in different capacities in India and abroad. She is recipient of several national awards including the Achari Prize, Uvnas Prize and the prestigious Prof. B.N. Ghosh Oration of the Indian Pharmacological Society. Her research interests are cardio-respiratory pharmacology & toxicology, traditional medicine and stress research, with specific reference to nitric oxide (NO). In recognition of her contributions to the medical sciences she is elected as Fellow of NAMS (India) and IACS (Canada). She is life member of se

Translating Nitric Oxide Research to therapeutics: a critical appraisal.- Nitric oxide and cardiovascular health.- Nitric oxide and cardiovascular diseases: Cardioprotection, Complications and Therapeutics.- Nitric Oxide and the Heart Autonomic Nervous System.- Exercise induced NO modulation in prevention and treatment of cardiovascular diseases.- Nitric Oxide and Cardio-renal Syndrome.- Nitric Oxide-cGMP-PKG Signaling in the Cardioprotective Effect of cGMP Specific Phosphodiesterase 5 Inhibitors.- Role of Nitric Oxide Synthases in Doxorubicin-Induced Cardiomyopathy.- Role of Nitric Oxide Synthase and Nitric Oxide Signaling in the Neutrophil Ontogeny and Functions.- Cell Death- NO-today: Effect of NO and RNS on non-apoptotic regulated cell death.- Involvement of nitric oxide in insulin secretion to carbohydrate metabolism.- Nitric Oxide : a diagnostic tool and therapeutic strategy in Respiratory Diseases.- Therapeutic potential of nitric oxide in the management of COVID-19 induced Acute Respiratory Distress Syndrome(ARDS).- Emerging Novel Therapies for COVID-19: Implications for the Use of Nitric Oxide as Anti-COVID-19 Therapy.- Sex differences in stress and stress related neuropsychiatric disorders: Focus on nitric oxide.- Nitric oxide in major depressive disorder.- Role of Nitric Oxide in Alzheimer`s Disease : Perspectives and Trends.- Nitric oxide in Parkinson's Disease: Insights into research and therapeutics.- Stable gastric pentadecapeptide BPC 157 and NO-system.- Exploring the gastroprotective, ulcer healing and chemopreventive properties of nitric oxide-releasing nonsteroidal anti-inflammatory drugs.- The role of nitric oxide in the etiopathogenesis of pre-eclampsia.- Therapeutic Prospects of Nitric Oxide as an Anti-Teratogen.- Ruthenium Nitrosyl Complexes: Photoinduced Delivery of NO to Different Biological Targets.- Nitric Oxide regulation in Microparticle.